Imunon, Inc. Files S-1 Registration Statement
Ticker: IMNN · Form: S-1 · Filed: Apr 4, 2025 · CIK: 749647
| Field | Detail |
|---|---|
| Company | Imunon, INC. (IMNN) |
| Form Type | S-1 |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: s-1, registration-statement, ipo-filing
TL;DR
Imunon (formerly Celsion) just filed an S-1, looks like they're prepping for a stock offering.
AI Summary
Imunon, Inc. filed an S-1 registration statement on April 4, 2025, to register securities under the Securities Act of 1933. The company, formerly known as Celsion Corp, is incorporated in Delaware and headquartered in Lawrenceville, NJ. This filing indicates a potential offering of securities, though specific details on the amount or type of securities are not yet provided in this excerpt.
Why It Matters
This S-1 filing signals Imunon, Inc.'s intent to potentially raise capital through a public offering, which could fund its operations and growth initiatives in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As an S-1 filing, it indicates a company is preparing to offer securities to the public, which inherently carries market and execution risks for investors.
Key Numbers
- 333-286403 — SEC File Number (Identifies this specific registration statement)
- 2834 — SIC Code (Indicates the company operates in Pharmaceutical Preparations)
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- 2834 (dollar_amount) — Standard Industrial Classification Code
- 521256615 (dollar_amount) — I.R.S. Employer Identification No.
- 333-286403 (dollar_amount) — SEC File Number
- April 4, 2025 (date) — Filing Date
- Stacy Lindborg (person) — President and Chief Executive Officer
FAQ
What is the purpose of this S-1 filing by Imunon, Inc.?
The S-1 filing is a registration statement required by the Securities Act of 1933, indicating Imunon, Inc.'s intent to offer securities to the public.
When was this S-1 filing submitted to the SEC?
The S-1 filing was submitted to the Securities and Exchange Commission on April 4, 2025.
What was Imunon, Inc. formerly known as?
Imunon, Inc. was formerly known as Celsion Corp, with previous name changes also noted from CELSION CORP and CHEUNG LABORATORIES INC.
Where is Imunon, Inc. headquartered?
Imunon, Inc.'s principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.
Who is the President and CEO of Imunon, Inc. mentioned in the filing?
Stacy Lindborg is listed as the President and Chief Executive Officer of Imunon, Inc.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on April 4, 2025 by Stacy Lindborg regarding Imunon, Inc. (IMNN).